Please login to the form below

Not currently logged in
Email:
Password:

23andMe

This page shows the latest 23andMe news and features for those working in and with pharma, biotech and healthcare.

FDA approves another home genetic testing service

FDA approves another home genetic testing service

FDA approves another home genetic testing service. 23andMe’s kit will check for an increased risk of certain cancers developing. ... The US Food and Drug Administration (FDA) has authorised another one of 23andMe’s home genetic kits, and this one

Latest news

More from news
Approximately 11 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Open minds for open innovation Open minds for open innovation

    In healthcare, programmes like 23andMe and PatientsLikeMe have demonstrated that this is a tangible tactic, despite the traditional need for high standards, strict regulation and rigorous process.

  • Pharma deals during January 2015 Pharma deals during January 2015

    Although not making the cut for our table, Genentech (Roche) closed a deal with 23andMe(the Google backed DNA screening test company) to use whole genome sequencing data to identify therapeutic

  • 23andMe signs Parkinson’s deal with Genentech 23andMe signs Parkinson’s deal with Genentech

    23andMe signs Parkinson’ s deal with Genentech. Adds to list of pharma tie-ups for genetic testing firm. ... The Google-backed genetic testing company 23andMe has penned a new research pact with Roche subsidiary Genentech.

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics